Atlas Trials

Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33

Clinical trial NCT03544905 · COMPLETED

Trial details

NCT number
NCT03544905
Sponsor
Haihe Biopharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2018-07-05
Primary completion
2024-12-04
Enrollment
206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.